Smartlab Europe

Japan To Make Its Preparedness & Response To Pandemic Robust

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

CMS Extends GENEROUS MFN Drug Pricing Deadline to April

The Centers for Medicare & Medicaid Services (CMS) in...

Lilly Launches New AI Supercomputer for Drug Development

Eli Lilly has launched what it describes as the...

Periodontal Disease as a Modifiable Risk Factor in Systemic Conditions

Periodontal disease has long been viewed primarily as a...
- Advertisement -

The Coalition For Epidemic Preparedness Innovation in Norway and the Strategic Centre of Biomedical Advanced Vaccine Research and Development for Preparedness and Response have gone on to sign a Memorandum of Cooperation- MoC so as to strengthen the partnership between both organisations as they look forward to speeding up global preparedness as well as response to any future pandemics.

Both CEPI and SCARDA have shared missions when it comes to funding the development of vaccines against diseases that are infectious and hence this new collaboration is going to assist the organisations in sharing expertise, experience, as well as knowledge and partner on the work areas that help contribute to the goals when it comes to both organisations.

It is well to be noted that by way of both partnerships, both organisations will be able to share information and insights on vaccine development, health security, manufacturing, and other themes that concern the preparedness of pandemics and epidemics. The partners will go ahead with a collaboration in terms of vaccine development in the case of priority pathogens as well as priority virus families of mutual interest, enabling them to select as well as focus when it comes to c complementary projects as well as investments sans duplicating the effort or even the resources.

CEPI and SCARDA will also look to coordinate on functions that go on to support the 100-Days mission, which happens to be embraced by the G7 as well as the G20 and which looks to speed up the time taken to create safe, effective, and accessible vaccines when it comes to emerging diseases having pandemic potential to 100 days.

Latest stories

Related stories

CMS Extends GENEROUS MFN Drug Pricing Deadline to April

The Centers for Medicare & Medicaid Services (CMS) in...

Lilly Launches New AI Supercomputer for Drug Development

Eli Lilly has launched what it describes as the...

Periodontal Disease as a Modifiable Risk Factor in Systemic Conditions

Periodontal disease has long been viewed primarily as a...

How Pharma is Navigating EPR’s Split-Tier Reality in 2026 without Losing Regulatory Sterility

In 2026, the Pharmaceutical and Medical Device sectors face...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »